Severe methotrexate hypersensitivity during treatment for Gestational trophoblastic Neoplasia: Case Report and considerations for management
Main Authors: | Ayesha Kar, Kathryn A. Mills |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-04-01
|
Series: | Gynecologic Oncology Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352578924000432 |
Similar Items
-
Comparison of Two Therapeutic Regimens: Methotrexate-Folinic Acid (8 days) and Weekly Methotrexate in Patients with Low risk Gestational Trophoblastic neoplasia
by: zahra honarvar, et al.
Published: (2018-11-01) -
Differences in Administration of Methotrexate and Impact on Outcome in Low-Risk Gestational Trophoblastic Neoplasia
by: Emelie Wallin, et al.
Published: (2022-02-01) -
Pneumocystis jirovecii pneumonia complicating methotrexate treatment in a patient with low-risk post-molar gestational trophoblastic neoplasia: A case report and review of the literature
by: Hector S. Porragas-Paseiro, et al.
Published: (2023-12-01) -
Comparison between single-agent chemotherapy in low-risk gestational trophoblastic neoplasia
by: Leila Mousavi Seresht, et al.
Published: (2023-01-01) -
Comparing biweekly single-dose actinomycin D with multiday methotrexate therapy for low-risk gestational trophoblastic neoplasia (FIGO Score 0–4): study protocol for a prospective, multicentre, randomized trial
by: Fang Jiang, et al.
Published: (2023-08-01)